Browse studies

Find your next paid study

3,234 recruiting studies matching your filters

A Phase 2 Study of Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (13C) in Patients With Prostate Cancer on Active Surveillance

This phase II trial studies the side how well hyperpolarized carbon C 13 pyruvate (HP C-13 pyruvate) magnetic resonance imaging (MRI) works in monitoring patie…

Prostate AdenocarcinomaProstate Cancer

Estimated

~$75 – $1,800

Actual pay is set by the research site.

University of California, San FranciscoNCT03933670

Observational

A Randomized, Sham Supplement- and Care-as-Usual-Controlled Study to Evaluate Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study

The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and b…

MigraineMigraine DiseaseMigraine Disorder+5 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Miracle Wellness LLCNCT07634146

Fetal Electrophysiologic Abnormalities in High-risk Pregnancies Associated With Fetal Demise

Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more commo…

High Risk PregnancyCongenital Heart DiseaseFetal Hydrops+16 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical College of WisconsinNCT03775954

Observational

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens (ANoPs)

The goal of this clinical study is to evaluate whether the NEO-Match® test, based on ARTIDIS nanomechanical profiling technology, can help predict treatment ou…

Pancreatic CancerPancreatic NeoplasmsPancreatic Ductal Adenocarcinoma (PDAC)+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

ARTIDIS AGNCT07542041

The Texas Interprofessional Pharmacogenomics (IPGx) PILOT Cohort

The investigator's primary aim is to evaluate polypharmacy-associated adverse drug reactions (ADR) in a pilot study of at-risk patients using state-of-the-art …

Adverse Drug Reaction

Estimated

~$10 – $750

Actual pay is set by the research site.

Texas A&M UniversityNCT06219720

Phase 1

A Phase 1b Trial of Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

This is a Phase 1b trial evaluating the combination of Fostamatinib, a Syk kinase inhibitor currently FDA-approved for chronic idiopathic thrombocytopenia purp…

Pancreatic Ductal Adenocarcinoma (PDAC)

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of California, San DiegoNCT06639724

Phase 1

Phase I Trial of ONC201 for Chemoprevention of Colorectal Cancer

The purpose of this phase I trial is to test the safety and cancer preventive effects of different doses of ONC201 in people with familial adenomatous polyposi…

Colorectal Adenomatous PolypColorectal CarcinomaFamilial Adenomatous Polyposis+1 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT05630794

Phase 1

Pathophysiological Mechanisms of Cannabidiol in Stress Regulation

Dysregulation in stress responsivity is a growing psychiatry-transdiagnostic fundamental phenomenon, with limited therapeutic strategies. With the legalization…

Early Life AdversityTraumaStress

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Icahn School of Medicine at Mount SinaiNCT07278505

Phase 1

A First-in-human (FIH), Multicenter, Open-Label, Phase Ia (Dose Escalation)/Phase Ib (Dose Expansion) Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

The goal of this clinical trial is to evaluate the safety and tolerability of escalating doses of PTX-912 in patients with locally advanced or metastatic solid…

Advanced CancerSolid TumorMetastatic Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Proviva Therapeutics, Inc.NCT06190886

Triggered Sacral Neuromodulation to Treat Neurogenic Detrusor Overactivity Based on Algorithmic Classification of Bladder Filling Status From Wireless Pressure Data

Incontinence associates with military service and post-traumatic stress disorder in both male and female Veterans. Neurogenic detrusor overactivity (NDO) is ca…

Urinary IncontinenceUrinary Bladder, Neurogenic

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT05141487

Phase 3

A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Fluorouracil (5-FU) in Patients With Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine

The study is designed to assess whether glufosfamide provides additional survival benefit as compared to bolus 5-FU in patients with metastatic pancreatic canc…

Metastatic Pancreatic Adenocarcinoma

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Eleison Pharmaceuticals LLC.NCT01954992

Phase 2

Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders

The goal of this study is to see whether kisspeptin, a naturally occurring hormone, can stimulate the release of other reproductive hormones in men and women w…

Hypogonadotropic Hypogonadism

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Stephanie B. Seminara, MDNCT05896293